This announcement is a separate document:
H.U.グループホールディングス：バイオジェンおよびBeckman Coulterとのアルツハイマー病に関する血液用検査試薬の開発にかかる提携について
H U Group Holdings: Partnership for the development of blood-based diagnostic reagents for Alzheimer's disease with biogen and Beckman Coulter.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated